Andhra Pradesh and Telangana: Indian contract manufacturing powerhouses for US API supply
In line with the global perception of a strong generics manufacturing industry in India, the...
Read More...
Focus:
India
-
![Boehringer Lupin agreement]()
Boehringer licences Lupin’s cancer asset in $720m deal
Germany-based Boehringer Ingelheim has entered into a licensing, development and commercialisation agreement worth more than...
Read More...
-
![Diabetes treatment]()
Glenmark wins regulatory approval to market diabetes drug in India
Glenmark Pharmaceuticals has achieved regulatory approval in India for its novel type 2 diabetes (T2D)...
Read More...
-
![Exelixis signs drug licensing deal with Aurigene]()
Exelixis signs drug licensing deal with Aurigene
US-based biotechnology company Exelixis has signed an exclusive collaboration, option and license agreement with India-based...
Read More...
-
![pharmaceutical industry in india]()
Northern India manufacturing on growth trajectory, but still lags behind south
Approximately 70% of all Indian pharmaceutical revenues will be from generics and revenue growth for...
Read More...
-
![GSK to divest Chiron Behring Vaccines to Bharat Biotech]()
GSK to divest Chiron Behring Vaccines to Bharat Biotech
GlaxoSmithKline (GSK) Asian subsidiary is set to divest its Chiron Behring Vaccines unit in Gujarat,...
Read More...
-
M&As this week: Strides Pharma Science, Lambda Therapeutic Research, NextPharma
Strides Pharma Science’s step-down subsidiary Strides Pharma has made an arrangement to acquire Vensun Pharmaceuticals...
Read More...
-
![]()
Can blockchain stem the tide of counterfeit drugs in India?
Counterfeit drugs are a multi-billion dollar problem. Now pharma companies are looking for a technological...
Read More...
-
M&As this week: Sun Pharma, Genentech, CVS Health
Sun Pharma has signed a definitive agreement to acquire Pola Pharma for $1m.
Read More...
-
M&As this week: Nestle Health, InvaGen, Takeda
Nestle Health has acquired a 19% stake in Aimmune Therapeutics for $98m.
Read More...